Navigation Links
Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee
Date:7/7/2010

Stone Research Foundation Publishes Study Results in The British Journal of Bone & Joint Surgery, Showing a 9.9 Year Survival Rate. Success of Less Invasive Procedures for Knee Damage Could Help Lower Skyrocketing Instances of Knee Replacement Surgery

San Francisco, CA (PRWEB) July 7, 2010 -- Biologic knee repair, rather than bionic (artificial) replacement, may slow the progression of arthritis without limiting the option for future arthroplasty, according to a study by Kevin R. Stone, MD, chairman, the Stone Research Foundation in this month’s issue of The British Journal of Bone & Joint Surgery. These research results could have significant impact on the long-term feasibility of artificial knee replacement - the number of artificial joint replacement surgeries is predicted to increase to 3.4 million by 2030, with proportionate increases in cost. The goal of biologic knee repair, according to Dr. Stone, is to avoid or forestall knee replacement surgery.

The report is based on a study of 119 meniscal allograft transplantations performed concurrently with articular cartilage repair in 115 patients with severe articular cartilage damage. The Kaplan-Meier estimated mean survival time for the whole series was 9.9 years. Loss of the meniscus generates increased forces on the articular cartilage of the knee and other joint structures and increases the risk of the development of arthritis. The appropriate treatment for loss of the meniscus with unicompartmental arthritis remains controversial, with treatments including osteotomy, unicompartmental (UKR) or total knee replacement. The study was approved by an independent Institutional Review Board. The study abstract is available via The British Journal of Bone & Joint Surgery.

Co-authors of the study with Dr. Stone are Ann W. Walgenbach, RNNP; Wendy Adelson, MS; Jonathan Pelsis, MHP; and Tom Turek of The Stone Research Foundation, San Francisco.

About The Stone Research Foundation:
The Stone Research Foundation is an independent, public, non-profit research institute based in San Francisco. Its mission is to research and develop ways to prevent, treat, and reverse arthritis and joint injuries. More info is available at www.stoneresearch.org.

###

Read the full story at http://www.prweb.com/releases/2010/07/prweb4231024.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Combination MMRV vaccine linked with 2-fold risk of seizures
2. Noninvasive combination technique may reduce number of breast biopsies
3. New combination effective against pancreatic cancer
4. Combination treatment regimen not effective against advanced melanoma
5. Combination therapy targets stubborn leukemia stem cells
6. Hair Loss Doctor Overcomes Odds To Produce First Ever Combination Topical Hair Growth Formula
7. Combination antibiotics effective against chlamydia-induced arthritis
8. Leeza Gibbons and ZERONA Equals a Winning Combination
9. Researchers find new chemotherapy combination shows promise in endometrial cancer
10. Combination Treatment May Help Depressed Alcoholics
11. Combination therapy more effective for enlarged prostate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee 
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: